Catalyst Pharmaceuticals Announces $200 Million Share Repurchase Program
Catalyst Pharmaceuticals Announces $200 Million Share Repurchase Program GlobeNewswire October 01, 2025 CORAL GABLES, Fla., Oct. 01, 2025 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing and commercializing novel medicines for people living with rare and difficult-to-treat diseases, today announced that its Board of […]